BR0110735A - ensaio de função de plaquetas e reagente para o mesmo - Google Patents

ensaio de função de plaquetas e reagente para o mesmo

Info

Publication number
BR0110735A
BR0110735A BRPI0110735-6A BR0110735A BR0110735A BR 0110735 A BR0110735 A BR 0110735A BR 0110735 A BR0110735 A BR 0110735A BR 0110735 A BR0110735 A BR 0110735A
Authority
BR
Brazil
Prior art keywords
reagent
platelet function
same
assay
function assay
Prior art date
Application number
BRPI0110735-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Donald E Mahan
Michael W Stewart
Original Assignee
Pharmanetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmanetics Inc filed Critical Pharmanetics Inc
Publication of BR0110735A publication Critical patent/BR0110735A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0110735-6A 2000-05-09 2001-05-09 ensaio de função de plaquetas e reagente para o mesmo BR0110735A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20263800P 2000-05-09 2000-05-09
PCT/US2001/011760 WO2001086248A2 (fr) 2000-05-09 2001-05-09 Dosage de fonction plaquettaire et reactif concu a cet effet

Publications (1)

Publication Number Publication Date
BR0110735A true BR0110735A (pt) 2007-05-08

Family

ID=22750704

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0110735-6A BR0110735A (pt) 2000-05-09 2001-05-09 ensaio de função de plaquetas e reagente para o mesmo

Country Status (9)

Country Link
EP (1) EP1280931A4 (fr)
JP (1) JP2003532891A (fr)
KR (1) KR20030014219A (fr)
AU (1) AU2001261020A1 (fr)
BR (1) BR0110735A (fr)
CA (1) CA2408850A1 (fr)
MX (1) MXPA02011017A (fr)
NO (1) NO20025300L (fr)
WO (1) WO2001086248A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680177B2 (en) * 2001-12-07 2004-01-20 Cardiovascular Diagnostics, Inc. Low molecular weight heparin assay, system and reagent therefor
JP4078247B2 (ja) 2003-05-02 2008-04-23 キヤノン株式会社 磁性体−生体物質複合体型構造体、磁性体に対して結合能を有するアミノ酸配列を有するペプチド断片及びその遺伝子、ならびに磁性体−生体物質複合体型構造体の製造方法
WO2011135397A1 (fr) * 2010-04-29 2011-11-03 University Of Calcutta Antiagrégant plaquettaire et procédés d'utilisation de celui-ci
KR101276179B1 (ko) * 2011-08-08 2013-06-18 고려대학교 산학협력단 혈소판 복합기능 검사 장치 및 방법, 이에 구비되는 미세교반칩
US8772040B2 (en) 2012-08-31 2014-07-08 Korea University Research And Business Foundation Apparatus and method of platelet multi-function analysis, and micro stirring chip

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110727A (en) * 1987-04-03 1992-05-05 Cardiovascular Diagnostics, Inc. Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles
US4849340A (en) * 1987-04-03 1989-07-18 Cardiovascular Diagnostics, Inc. Reaction system element and method for performing prothrombin time assay
TW221493B (fr) * 1990-07-10 1994-03-01 Cardiovascular Diagnostics Inc
US5616311A (en) * 1991-01-15 1997-04-01 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
US5446132A (en) * 1992-10-01 1995-08-29 The General Hospital Corporation Thrombin-activated platelet protein-2 (TAPP-2)
US5427913A (en) * 1992-12-03 1995-06-27 Alberta Cancer Board Methods for determining platelet function
EP0685069A4 (fr) * 1993-02-17 2002-01-23 Cardiovascular Diagnostics Inc Dosage immunologique et dosage par affinite en cascade par voie seche
US5686597A (en) * 1995-06-06 1997-11-11 Incyte Pharmaceuticals, Inc. Thrombin receptor homolog
US5922551A (en) * 1997-03-20 1999-07-13 Accumetrics, Inc. Agglutrimetric platelet binding assays in blood
US6046051A (en) * 1997-06-27 2000-04-04 Hemosense, Inc. Method and device for measuring blood coagulation or lysis by viscosity changes
US5932445A (en) * 1997-11-07 1999-08-03 Incyte Pharmaceuticals, Inc. Signal peptide-containing proteins

Also Published As

Publication number Publication date
KR20030014219A (ko) 2003-02-15
NO20025300D0 (no) 2002-11-05
WO2001086248A3 (fr) 2002-02-28
WO2001086248A2 (fr) 2001-11-15
EP1280931A2 (fr) 2003-02-05
NO20025300L (no) 2003-01-07
EP1280931A4 (fr) 2005-02-09
AU2001261020A1 (en) 2001-11-20
JP2003532891A (ja) 2003-11-05
CA2408850A1 (fr) 2001-11-15
MXPA02011017A (es) 2004-08-19

Similar Documents

Publication Publication Date Title
WO2002039949A3 (fr) Dosage de reaction thrombocytes / leucocytes et reactif prevu a cet effet
Behbehani et al. Transient partial permeabilization with saponin enables cellular barcoding prior to surface marker staining
EP0227173A3 (en) New method for the detection of specific binding agents and their corresponding bindable substances
DE69506434D1 (de) Blutplättchen blockade test
IL57722A0 (en) Dispersed metal particle labelled assay method and kit and reagents for use therein
DE69816474D1 (de) Stabilisierte teilchen deren herstellung und anwendung
DE69230105D1 (de) Differentielle bindungsaffinitäten und darauf beruhende dissoziationstestverfahren
JP2005503534A5 (fr)
KR890012165A (ko) 이온-포획 분석방법 및 장치
BR0215327A (pt) sistema de calibração interna para ensaios de circulação de fluxo
AR010364A1 (es) Un procedimiento para la determinacion de un objeto de analisis en un liquido de prueba mediante aglutinacion, particulas sinteticas como reactivo de aglutinacion para dicho procdimiento y un conjunto de implementos reactivos ("kit") que contiene dichas particulas.
DE60128794D1 (de) Multianalyt-diagnostizierverfahren für schilddrüsenstörungen
BR0110735A (pt) ensaio de função de plaquetas e reagente para o mesmo
KR890702039A (ko) 1,25-디하이드록시 비타민 d의 분석 방법
Spurgeon et al. OMIP‐097: High‐parameter phenotyping of human platelets by spectral flow cytometry
Houslay et al. Lysophosphatidylcholines can modulate the activity of the glucagon-stimulated adenylate cyclase from rat liver plasma membranes
WO2006051548A3 (fr) Procede, systeme et dispositif de typage sanguin
WO2005106047A3 (fr) Detection d'interactions moleculaires
Beke Debreceni et al. L‐Selectin Expression is Influenced by Phosphatase Activity in Chronic Lymphocytic Leukemia
CN103149350A (zh) 一种纳米磁微粒与抗体偶联的方法
BR9913770A (pt) Processo de ensaio para determinação da cobalamina ligada a transcobalamina ii (tcii) em uma amostra de corpo, kit para uso em um ensaio diagnóstico, e, uso de holo-tc ii
DE69229960D1 (de) Agglutierungsassays und kolloide farbstoffe verwendende testsätze
ES8707342A1 (es) Un metodo de medida de la concentracion de un ligando libre en un fluido biologico
Donato et al. Specific binding sites for S‐100 protein in isolated brain nuclei
IT1254858B (it) Metodo per la determinazione della frazione libera di sostanze presenti nei fluidi biologici.